Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Opthea Limited (AU:OPT)
ASX:OPT
Opthea Limited (OPT) Share Price & Analysis
19 Followers
OPT Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.29 - AU$0.75
Previous CloseAU$0.41
Volume1.04M
Average Volume (3M)2.20M
Market Cap
AU$488.47M
Enterprise ValueAU$355.32M
Total Cash (Recent Filing)$89.19M
Total Debt (Recent Filing)$181.71K
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Aug 29, 2024EPS Estimate
-AU$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.41
Shares Outstanding662,808,634
10 Day Avg. Volume1,187,547
30 Day Avg. Volume2,196,879
Standard Deviation0.46
R-Squared0.00201
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)-22.65
Price to Sales (P/S)13940.22
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.28K
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.70Price Target Upside69.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Opthea Limited News
PremiumCompany Announcements
Opthea Limited Reports Major Shareholding Changes
PremiumCompany Announcements
Opthea Sees Significant Holder’s Voting Power Dip
PremiumCompany Announcements
Opthea Limited Top Shareholders Revealed
PremiumCompany Announcements
Opthea Limited Expands Market Presence
Options Prices
Currently, No data available
---
Ownership Overview
0.34% Insiders
1.44% Mutual Funds
1.48% Other Institutional Investors
96.74% Public Companies and
Individual Investors
OPT FAQ
What was Opthea Limited’s price range in the past 12 months?
Opthea Limited lowest share price was AU$0.29 and its highest was AU$0.75 in the past 12 months.
What is Opthea Limited’s market cap?
Currently, no data Available
When is Opthea Limited’s upcoming earnings report date?
Opthea Limited’s upcoming earnings report date is Aug 29, 2024 which is in 33 days.
How were Opthea Limited’s earnings last quarter?
Opthea Limited released its earnings results on Feb 28, 2024. The company reported -AU$0.22 earnings per share for the quarter, missing the consensus estimate of -AU$0.163 by -AU$0.057.
Is Opthea Limited overvalued?
According to Wall Street analysts Opthea Limited’s price is currently Undervalued.
Does Opthea Limited pay dividends?
Opthea Limited does not currently pay dividends.
What is Opthea Limited’s EPS estimate?
Opthea Limited’s EPS estimate is -AU$0.23.
How many shares outstanding does Opthea Limited have?
Opthea Limited has 1,206,094,400 shares outstanding.
What happened to Opthea Limited’s price movement after its last earnings report?
Opthea Limited reported an EPS of -AU$0.22 in its last earnings report, missing expectations of -AU$0.163. Following the earnings report the stock price went down -9.245%.
Which hedge fund is a major shareholder of Opthea Limited?
Currently, no hedge funds are holding shares in AU:OPT
---
Opthea Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.70 (69.11% Upside)
AU$0.70 (69.11% Upside)
Blogger Sentiment
Bullish
AU:OPT Sentiment 96%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.58%
12-Months-Change
Fundamentals
Return on Equity
-3383.08%
Trailing 12-Months
Asset Growth
8.11%
Trailing 12-Months
Company Description
Opthea Limited
Opthea Ltd. is engaged in the development of biological therapeutics for cancer and other serious diseases. It is a biologics drug developer building on significant intellectual property portfolio around Vascular Endothelial Growth Factor C and D angiogenic molecules and R3. The company focuses on vascular endothelial growth factors to develop truly novel therapies to extend and improve the lives of cancer sufferers. Opthea was founded on October 17, 1984 and is headquartered in South Yarra, Australia.
---
OPT Stock 12 Month Forecast
Average Price Target
AU$0.70
▲(69.11% Upside)
Technical Analysis
Omeros
―
Corbus Pharmaceuticals
―
Kodiak Sciences
―
Aldeyra Therapeutics
―
Opthea Limited
―
Best Analysts Covering OPT
1 Year
1 Year Success Rate
1/4 ratings generated profit
1 Year Average Return
-7.40%
downgraded a sell rating 11 months ago
Copying Melissa Benson's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -7.40% per trade.
---